The Board proposes the rule amendment to 64B13-3.002, F.A.C. to delete language that is a restatement of subsection 456.057(2), F.S., and to renumber the rule accordingly; the proposed amendment to 64B13-3.006, F.A.C. is to delete language that is a restatement of subsection 463.011, F.S. from the rule and to renumber the rule accordingly; the proposed amendment to 64B13-3.008, F.A.C., is to delete language from the rule that is a restatement of subsections 463.001, 463.002, 463.014, and 483.002, F.S., and to renumber the rule accordingly; The proposed amendment to 64B13-3.009 is to delete language that is a policy statement and does not constitute a rule, restates subsection 463.016, F.S., and delete language that contradicts Florida Statutes and to renumber the rule accordingly; the proposed amendment to 64B13-3.010 is to delete language that restates subsections 463.016, 463.0135, and 463.072, F.S. and to add language to clarify administration and prescription of ocular pharmaceutical agents, and to renumber the rule accordingly; the proposed amendment to 64B13-3.012 is to delete unnecessary language from the rule and renumber the rule accordingly; the proposed amendment to 64B13-3.015 is to delete language from the rule that is a restatement of subsection 463.009, F.S. and renumber the rule accordingly.